Company intelligence / Profile preview
Merix Pharmaceutical
- Ownership
- Private
- Employees
- ~7
- Development stage
- Commercial
Overview
Merix Pharmaceutical markets over-the-counter antiviral products based on patented phyto-chemical formulas, notably for cold sore (herpes labialis) symptom relief; clinical effectiveness beyond OTC indications is not published in scientific literature, but the company's flagship product, RELEEV, is widely available in US pharmacies.[1][3][5][9]
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculePhyto-pharmaceutical
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Merix Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Merix Pharmaceutical.